Inhibits glucagon
In contrast, BPC 157 is more focused on specific tissue types, particularly in reducing inflammation and accelerating recovery in localized injuries
[DOI] [PMC free article] [PubMed] [Google Scholar] 68.Nashawi H, Gustafson TJ, Mietlicki-Baase EG
Basic polymeric nanocarrier systems significantly enhance the therapeutic efficacy in gout treatment through multi-pathway synergistic mechanisms
"These drugs enhance feelings of fullness and help limit carbohydrate intake, resulting in greater weight loss and glycemic control." Despite having "GLP-1" in the name, the new Lemme supplement doesn't actually contain synthetic GLP-1
The major difference in their chemical structures is the -OH group of lutein which diverges their distribution in the cell membrane, solubility, stability, and activity 38,41